Loading...
10 North America Psychological Syndrome Reports
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc., Allergan PLC, AstraZeneca Plc, GlaxoSmithKline Plc, Janssen Pharmaceuticals Inc.
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc,, GlaxoSmithKline, Merck & Co. Inc, Eli Lily & Co, Johnson & Johnson
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson, Eli Lilly and Company, AbbVie Inc.(Allergan Plc), Alkermes PLC, Otsuka Pharmaceutical Inc.
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca, Pfizer, GlaxoS, Eli Lilly and Company , Johnson and Johnson
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lily & Company, Pfizer, Lupin, Mallinckrodt , Purdue Pharma L.P
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, H. Lundbeck A/S, GSK plc, Otsuka Pharmaceutical Co., Ltd., Pfizer, Inc.
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Lupin Limited , Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc., Merck KGaA
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, United Kingdom, France, Germany, Italy, Spain, India, China, Japan, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Bausch Health Companies Inc., Lilly, Sage Therapeutics, Inc., Cipla Inc.
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: PaxMedica, Yamo Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, Q BioMed Inc.
Region Covered: North America
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson and Johnson, Teva Pharmaceuticals, Aurobindo Pharma, Zydus Cadila, Eli Lilly and Company
Filter Reports
By Countries
